Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Celsion Corporation (CLSN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Celsion Corporation is a leading oncology company specializing in the development and commercialization of cancer drugs, including tumor-targeting treatments that utilize focused heat energy combined with heat-activated liposomal drug technology. Celsion has research, license or commercialization agreements with such leading institutions as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, UCLA Department of Medicine, the University of Pisa, Kyungpook National University Hospital and the Beijing Cancer Hospital. For more information, visit the company’s Web site at www.celsion.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *